Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-10-01-2001
Volume0
Issue 0

PBMs: Merck-Medco in the Hot Seat

Author(s):

Andra Brichacek

Franklin Lakes, New Jersey-Merck’s pharmacy benefit arm, Merck-Medco, is under fire for switching patients to more expensive pharmaceuticals.

Articles in this issue
National Crisis Supercedes Coverage Debate
PBMs: Merck-Medco in the Hot Seat
National Crisis Supercedes Coverage Debate
image4-686-1409031567502.gif
A Five-Year Forecast: Clear Seas Ahead?
Weak Bones, Strong Market
Weak Bones, Strong Market
Approvals: Novartis’ Silver Lining

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Gen Li
Related Content
Stock.adobe.com
August 14th 2025

Seal Rock Therapeutics Unites with The Michael J. Fox Foundation’s LITE Program Advancing Parkinson’s Disease Therapies

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 14th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
adobe.stock.com
August 14th 2025

Oikos Announces GLP-1 Inspired Drink Designed for Retaining Muscle Mass During Weight Loss

Nicholas Jacobus
Beyond the Prescription: Pharma's Role in Digital Health Conversations
August 14th 2025

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Canopy
CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy
August 14th 2025

CIT Therapeutics and Institute for Follicular Lymphoma Innovation Launch Multimillion Dollar Partnership to Advance Cancer Therapy

Don Tracy, Associate Editor
Site Logo
August 14th 2025

AI in Drug Discovery On-Demand Webinar

AlphaSense